Loading…
Loading…
EQUITY / NASDAQ · XNAS
Co-Diagnostics Inc.
01 / RESEARCH
8 financial reports are available for research.
Start research ↗1.07 USD
Observed: 09/30/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
09/30/2026 · 1.07 USD · Volume 87,382
62 actual observations · Latest bar: 2026-09-30 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Cash and cash equivalents | 3,649,632 USD | — | — |
| Gross profit | 120,828 USD | 130,804 USD | -7.63% |
| Net income | -6,283,786 USD | -7,730,117 USD | — |
| Operating profit | -6,200,783 USD | -8,057,764 USD | — |
| Revenue | 166,131 USD | 162,910 USD | +1.98% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2025 / Quarter 2ConsolidatedUnits · USD | 2025 / Year endConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD | 2025 / Quarter 2ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 3,649,632 USD | — | — | 11,884,607 USD | 11,884,607 USD | 11,443,943 USD | — | — |
| Gross profitIncome statement | 120,828 USD | 73,013 USD | — | — | 400,112 USD | 119,095 USD | 278,586 USD | 130,804 USD |
| Net incomeIncome statement | -6,283,786 USD | -15,423,824 USD | -9,140,038 USD | — | -46,895,936 USD | -5,886,823 USD | -21,150,211 USD | -7,730,117 USD |
| Operating profitIncome statement | -6,200,783 USD | -15,409,196 USD | — | — | -50,165,352 USD | -7,013,848 USD | -23,623,568 USD | -8,057,764 USD |
| RevenueIncome statement | 166,131 USD | 312,084 USD | — | — | 622,489 USD | 145,380 USD | 358,567 USD | 162,910 USD |
| Total assetsBalance sheet | 16,590,631 USD | — | — | 24,742,585 USD | 24,742,585 USD | 44,740,761 USD | — | — |
| Total equityBalance sheet | 12,712,349 USD | — | 16,042,410 USD | 20,628,664 USD | 20,628,664 USD | 39,828,245 USD | — | 40,701,633 USD |
| Total liabilitiesBalance sheet | 3,878,282 USD | — | — | 4,113,921 USD | 4,113,921 USD | 4,912,516 USD | — | — |
| Capital expendituresCash flow statement | — | 160,298 USD | — | — | 700,047 USD | — | 568,078 USD | — |
| Financing cash flowCash flow statement | — | 7,074,643 USD | — | — | 11,811,583 USD | — | 4,842,198 USD | — |
| Investing cash flowCash flow statement | — | -310,298 USD | — | — | 26,273,407 USD | — | 26,602,830 USD | — |
| Operating cash flowCash flow statement | — | -14,999,320 USD | — | — | -29,136,927 USD | — | -22,937,629 USD | — |
| Report source | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 03/31/2026 | Open report ↗ Published: 11/13/2025 | Open report ↗ Published: 11/13/2025 | Open report ↗ Published: 08/13/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.